Regulus Therapeutics
RGLS
#7287
Rank
$0.56 B
Marketcap
$8.16
Share price
0.00%
Change (1 day)
436.84%
Change (1 year)

EPS for Regulus Therapeutics (RGLS)

EPS in 2025 (TTM): -$0.73

According to Regulus Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.73. In 2024 the company made an earnings per share (EPS) of -$0.87.

EPS history for Regulus Therapeutics from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-$0.73-16.09%
2024-$0.87
2022-$1.86-43.12%
2021-$3.27-40.55%
2020-$5.50-50%
2019-$11.00-80.36%
2018-$56.00-57.8%
2017-$132.70-28.66%
2016-$186.0042.2%
2015-$130.80-14.84%
2014-$153.60156%
2013-$60.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
$1.98-371.31%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
$2.36-423.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$4.52-719.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$7.12-1,075.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
$2.88-494.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-$0.38-47.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$19.81-2,813.70%๐Ÿ‡บ๐Ÿ‡ธ USA